Posters
Academic Level (Author 1)
Medical Student
Academic Level (Author 2)
Medical Student
Academic Level (Author 3)
Medical Student
Academic Level (Author 4)
Medical Student
Academic Level (Author 5)
Faculty
Discipline/Specialty (Author 5)
Obstetrics and Gynecology
Discipline Track
Community/Public Health
Abstract
Background: With the overturning of Roe v. Wade, the management of women who are family planning has become more complex, highlighting the necessity for comprehensive and informed healthcare. This case report underscores the importance of holistic, interdisciplinary care for women with chronic conditions like Chronic Myeloid Leukemia (CML) who are planning for pregnancy. The novelty lies in the interplay between oncological treatment and reproductive health under current legal constraints.
Case Presentation: We present the case of a 32-year-old woman, G2P0010, with a history of CML and a previous spontaneous abortion. Initially believed to be in remission, she was started on Bosutinib, a second-generation tyrosine kinase inhibitor (TKI), without discussion of its teratogenic risks. At approximately three weeks gestation, early pregnancy was confirmed. A multidisciplinary team involving maternal-fetal medicine and oncology recommended continuing Bosutinib due to molecular response detected by PCR, after thoroughly discussing the risks and benefits to both mother and fetus. Information about current abortion laws and future pregnancy possibilities upon achieving complete remission was provided. The patient and her husband, initially distressed, felt reassured and hopeful after comprehensive counseling.
Conclusions: This case emphasizes the critical need for interdisciplinary care and proactive family planning discussions in the management of fertile women. Clear, comprehensive communication and patient education are essential to mitigate risks associated with teratogenic treatments and to support informed reproductive choices, particularly in the context of evolving legal and medical landscapes. This approach ensures optimal outcomes for both mother and child, highlighting the clinician’s duty to integrate family planning into patient care discussions.
Presentation Type
Poster
Recommended Citation
Monie, Hermione Yamyo; Al Hassan, Taha; Roca, Salomon Pardo; Ehiemua, Uchechi; and Leal, Ramiro, "Unique Considerations in the Management of Healthcare Among Fertile Women A Case Report on Chronic Myeloid Leukemia and Pregnancy" (2024). Research Colloquium. 73.
https://scholarworks.utrgv.edu/colloquium/2024/posters/73
Included in
Hemic and Lymphatic Diseases Commons, Medical Jurisprudence Commons, Obstetrics and Gynecology Commons, Oncology Commons
Unique Considerations in the Management of Healthcare Among Fertile Women A Case Report on Chronic Myeloid Leukemia and Pregnancy
Background: With the overturning of Roe v. Wade, the management of women who are family planning has become more complex, highlighting the necessity for comprehensive and informed healthcare. This case report underscores the importance of holistic, interdisciplinary care for women with chronic conditions like Chronic Myeloid Leukemia (CML) who are planning for pregnancy. The novelty lies in the interplay between oncological treatment and reproductive health under current legal constraints.
Case Presentation: We present the case of a 32-year-old woman, G2P0010, with a history of CML and a previous spontaneous abortion. Initially believed to be in remission, she was started on Bosutinib, a second-generation tyrosine kinase inhibitor (TKI), without discussion of its teratogenic risks. At approximately three weeks gestation, early pregnancy was confirmed. A multidisciplinary team involving maternal-fetal medicine and oncology recommended continuing Bosutinib due to molecular response detected by PCR, after thoroughly discussing the risks and benefits to both mother and fetus. Information about current abortion laws and future pregnancy possibilities upon achieving complete remission was provided. The patient and her husband, initially distressed, felt reassured and hopeful after comprehensive counseling.
Conclusions: This case emphasizes the critical need for interdisciplinary care and proactive family planning discussions in the management of fertile women. Clear, comprehensive communication and patient education are essential to mitigate risks associated with teratogenic treatments and to support informed reproductive choices, particularly in the context of evolving legal and medical landscapes. This approach ensures optimal outcomes for both mother and child, highlighting the clinician’s duty to integrate family planning into patient care discussions.